We show that YAP1/WWTR1/TEAD-dependent transcription is acutely activated following treatment of EGFR mutant lung cancer cells with EGFR inhibitors and that prevention of YAP1/WWTR1 activation strongly suppresses cancer cell persistence. The gene discussed is EGFR; the disease is lung carcinoma.